Doher Drizzle Pablo was drowning in travel receipts. After her company transferred her to Sweden from the Philippines last year, she’d started visiting clients in at least two countries a month, and ...

Microbot Medical ( (MBOT)) has issued an announcement. On November 5, 2025, Microbot Medical announced the limited commercial availability of its LIBERTY® Endovascular Robotic System in the U.S. This ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Fintel reports that on October 15, 2025, HC Wainwright & Co. reiterated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 325.00% Upside As of ...

Microbot Medical Inc. (MBOT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...

We recently published 10 Stocks Losing Big Amid Market Boom. Microbot Medical Inc. (NASDAQ:MBOT) is one of the worst performers on Thursday. Microbot extended its losing streak to a fourth consecutive ...

MBOT’s main value driver is its LIBERTY robot. This is a disposable, portable endovascular robot that has great potential. LIBERTY showed strong ACCESS-PVI data and now awaits FDA 510(k) clearance for ...

As companies like Amazon and Microsoft lay off workers and embrace A.I. coding tools, computer science graduates say they’re struggling to land tech jobs. Manasi Mishra recently graduated from Purdue ...

In 2022, this series was expanded into a book, edited by Torie Bosch. Read “You Are Not Expected to Understand This”: How 26 Lines of Code Changed the World here. Back in 2009, Facebook launched a ...

The Electrical and Computer Engineering Building, which connects to the Paul G. Allen Center for Computer Science & Engineering, on a sunny afternoon in June 2025. (GeekWire Photo / Lisa Stiffler) The ...

Microbot Medical Inc. (MBOT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...